| Application no. and date | 15787846.3 (espacenet) (Federated) (European Patent Register), 20151021 | | Patent/reg. no. and date | DK/EP 3209647, 20200603 | | Publication date | 20170830 | | Priority no. and date | US 201462066849 P, 20141021 | | EP pub. no. and date |
EP 3209647 20170830 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi
Osaka, JP | | Applicant ref. no. | 113037 ARIAD-TPC 4 | | Inventor | SHARMA, Pradeep, 25 Fletcher Road
Westford, MA 01886, US,
ROZAMUS, Leonard, W., 1 Stouffer Circle
Andover, MA 01810, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 239/48 (2006.01) | | Title | KRYSTALLINSKE FORMER AF 5-CHLOR-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDIN-2,4-DIAMIN | | Int. application no. | US2015056701 | | Int. publication no. | WO2016065028 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
